Glycophenotype of prostatic carcinomas

Folia Histochemica et Cytobiologica

Volumn 48, Issue 4, 2010, Pages 637-645

  Khabaz, M N ^a   McClure, J ^b   McClure, S ^b   Stoddart, R W ^b  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Lectin; Lewis antigens; Prostatic carcinoma

Indexed keywords

AGGLUTININ; ANGUILLA ANGUILLA AGGLUTININ; ARACHIS HYPOGAEA AGGLUTININ; AVIDIN; BIOTIN; DOLICHOS BIFLORUS AGGLUTININ; ERYTHRINA CORALLODENDRON AGGLUTININ; ERYTHRINA CRISTAGALLI AGGLUTININ; GALANTHUS NIVALIS AGGLUTININ; GLYCAN; GLYCOPROTEIN; GRIFFONIA SIMPLICIFOLIA AGGLUTININ; HELIX POMATIA AGGLUTININ; LECTIN; MAAKIA AMURENSIS AGGLUTININ; MACLURA POMIFERA AGGLUTININ; MONOCLONAL ANTIBODY; NARCISSUS PSEUDONARCISSUS AGGLUTININ; OLIGOSACCHARIDE; PEROXIDASE; SAMBUCUS NIGRA AGGLUTININ; SIALYL LEWIS X ANTIGEN; SOYBEAN AGGLUTININ; TAGONOLOBUS PURPUREUS AGGLUTININ; ULEX EUROPAEUS AGGLUTININ; UNCLASSIFIED DRUG; VICIA VILLOSA AGGLUTININ; WISTERIA FLORIBUNDA AGGLUTININ;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; AUTOPSY; BIOTINYLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FUCOSYLATION; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PHENOTYPIC VARIATION; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; QUANTITATIVE ANALYSIS; SIALYLATION; TISSUE SECTION;

EID: 79958204983     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.2478/v10042-010-0089-9     Document Type: Article

References (25)

1. Ogawa J, Sano A, Inoue H, Koide S. Expression of Lewisrelated antigen and prognosis in stage I non-small cell lung cancer. Ann Thorac Surg. 1995;59:412-415.
2. Hakomori S. Aberrant glycosylation in tumours and tumourassociated carbohydrate antigens. Adv Cancer Res. 1989;52: 257-331.
3. Ito N, Hirota T. Histochemical and cytochemical localization of blood group antigens. Prog Histochem Cytochem. 1992; 25:1-85.
4. Jones CJ, Stoddart RW. A post-embedding avidin-biotin peroxidase system to demonstrate the light and electron microscopic localization of lectin binding sites in rat kidney tubules. Histochem J. 1986;18:371-379.
5. Downs F, Herp A, Moschera J, Pigman W. Beta-elimination and reduction reactions and some applications of dimethylsulfoxide on submaxillary glycoproteins. Biochim Biophys Acta. 1973;328:182-192.
6. Arenas MI, Romo E, de Gaspar I, de Bethencourt FR, Sánchez-Chapado M, Fraile B, Paniagua R. A lectin histochemistry comparative study in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma. Glycoconj J. 1999;16:375-382.
7. Abel PD, Keane P, Leathem A, Tebbutt S, Williams G. Change in glycoconjugate for the binding site of the lectin Ulex europeus 1 following malignant transformation of prostatic epithelium. Br J Urol. 1989;63:183-185.
8. Söderstrom KO. Lectin binding to prostatic adenocarcinoma. Cancer. 1987;60:1823-1831.
9. McMahon RF, McWilliam LJ, Clarke NW, George NJ. Altered saccharide sequences in two groups of patients with metastatic prostatic carcinoma. Br J Urol. 1994;74:80-85.
10. Loy TS, Kyle J, Bickel JT. Binding of soybean agglutinin lectin to prostatic hyperplasia and adenocarcinoma. Cancer. 1989;63:1583-1586.
11. McNeal JE, Alroy J, Villers A, Redwine EA, Freiha FS, Stamey TA. Mucinous differentiation in prostatic adenocarcinoma. Hum Pathol. 1991;22:979-988.
12. Drachenberg CB, Papadimitriou JC. Aberrant pattern of lectin binding in low and high grade prostatic intraepithelial neoplasia. Cancer. 1995;75:2539-2544.
13. Young WW Jr, Mills SE, Lippert MC, Ahmed P, Lau SK. Deletion of antigens of the Lewis a/b blood group family in human prostatic carcinoma. Am J Pathol. 1988;131:578-586.
14. Perlman EJ, Epstein JI. Blood group antigen expression in dysplasia and adenocarcinoma of the prostate. Am J Surg Pathol. 1990;14:810-818.
15. Idikio HA, Manickavel V. Correlation of blood group antigen expression and oncogene-related proteins in malignant prostatic tissues. Pathol Res Pract. 1991;187:189-197.
16. Zhang S, Zhang HS, Cordon-Cardo C, Reuter VE, Singhal AK, Lloyd KO, Livingston PO. Selection of tumour antigens as targets for immune attack using Immunohistochemistry: II. Blood group-related antigens. Int J Cancer. 1997;73:50-56.
17. Jorgensen T, Berner A, Kaalhus O, Tveter KJ, Danielsen HE, Bryne M. Up-regulation of the oligosaccharide sialyl Lewisx: a new prognostic parameter in metastatic prostate cancer. Cancer Res. 1995;55:1817-1819.
18. Martensson S, Bigler SA, Brown M, Lange PH, Brawer MK, Hakomori S. Sialyl-Lewis(x) and related carbohydrate antigens in the prostate. Hum Pathol. 1995;26:735-739.
19. Jorgensen T, Kanagasingam Y, Kaalhus O, Tveter KJ, Bryne M, Skjørten F, Berner A, Danielsen HE. Prognostic factors in patients with metastatic (stage D2) prostate cancer: experience from the Scandinavian Prostatic Cancer Group Study-2. J Urol. 1997;158:164-170.
20. Idikio HA. Sialyl-Lewis-X, Gleason grade and stage in nonmetastatic human prostate cancer. Glycoconj J. 1997;14:875-877.
21. Foster CS, McLoughlin J, Bashir I, Abel PD. Markers of the metastatic phenotype in prostate cancer. Hum Pathol. 1992;23:381-394.
22. Janssen T, Petein M, Van Velthoven R, Van Leer P, Fourmarier M, Vanegas JP, Danguy A, Schulman C, Pasteels JL, Kiss R. Differential histochemical peanut agglutinin stain in benign and malignant human prostate tumours: relationship with prostatic specific antigen immunostain and nuclear DNA content. Hum Pathol. 1996;27:1341-1347.
23. Fukuda M. Possible roles of tumour-associated carbohydrate antigens. Cancer Res. 1996;56:2237-2244.
24. Hakomori S. Tumour-associated carbohydrate markers. In: Serological cancer markers, Sell S (Ed) Human Press, New Jersey, 1992, pp 207-232.
25. Aubert M, Panicot L, Crotte C, Gibier P, Lombardo D, Sadoulet MO, Mas E. Restoration of alpha (1, 2) fucosyltransferase activity decreases adhesive and metastatic properties of human pancreatic cancer cells. Cancer Res. 2000;60: 1449-1456.